Asia-Pacific Fetal & Neonatal Monitoring Market Size (2024 - 2029)

The Asia-Pacific fetal and neonatal monitoring market is anticipated to experience growth over the forecast period, driven by factors such as a high birth rate and the prevalence of preterm births in the region. The market's expansion was initially hindered by the COVID-19 pandemic due to strict governmental regulations that disrupted neonatal care. However, the resumption of healthcare practices post-pandemic is expected to contribute positively to the market's growth. Additionally, increasing awareness campaigns and strategic collaborations among market players are likely to further support the market's development. Despite these positive trends, challenges such as limited accessibility and stringent regulatory procedures may impede the market's growth in certain areas.

Market Size of Asia-Pacific Fetal & Neonatal Monitoring Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Asia-Pacific Fetal and Neonatal Monitoring Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 6.20 %

Major Players

Asia-Pacific Fetal and Neonatal Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Asia-Pacific Fetal and Neonatal Monitoring Market Analysis

The Asia-Pacific fetal and neonatal monitoring market is expected to register a CAGR of 6.2% over the forecast period.

COVID-19 had a significant impact on the growth of the market during the pandemic period in Asia-Pacific. This was due to the strict regulations imposed by the governments in the Asia-Pacific region leading to disruptions in neonatal care, which led to a notable impact on the market's growth. For instance, the article published by BMJ in 2021 mentioned that the pandemic affected newborn follow-up care, with 48.5% of patients reporting fewer appointments per newborn and 32.6% reporting fewer staff to conduct follow-up clinics in Asia. Such reduction in neonatal and fetal care in Asian countries during the pandemic period significantly impacted the market's growth. However, the resumption of neonatal and fetal healthcare practices after the relaxation of strict lockdown regulation during the post-pandemic period is expected to drive the market's growth over the forecast period.

The high birth rate and preterm births in the Asia-Pacific population are the major factors boosting the market studied. According to the Frontiers article published in July 2022, 52.9% of births will be preterm n Asia in 2021. the article also mentioned that India accounted for 23.4% of preterm births worldwide, China for 7.8%, Bangladesh for 4.0%, and Indonesia for 3.5% of the total preterm birth rates worldwide. Preterm babies often require special care in the neonatal intensive care unit (NICU). The demand for neonatal devices is also increasing, which is expected to be a key driving force for the studied market.

Additionally, the increasing strategies of the market players, such as collaborations, partnerships, and others, and rising launches of various awareness campaigns regarding fetal and neonatal healthcare in Asia-Pacific countries are also expected to drive the market's growth. For instance, in October 2021, Melody International collaborated with Abdul Latif Jameel Health to distribute Melody's innovative remote Melody I Mobile Fetal Monitor iCTG, a cloud-based wireless fetal monitor program across the Asian market. Also, in November 2022, the Director of Health Services at UT Ladakh launched the SAANS campaign in Ladakh to increase awareness and reduce the infant mortality rate in this region.

Thus, the high prevalence of preterm births, the presence of major market players, and rising awareness among the Asia-Pacific population are expected to fuel the market's growth over the forecast period. However, the limited accessibility and stringent regulatory procedures are expected to hinder market growth in this region.

Asia-Pacific Fetal and Neonatal Monitoring Industry Segmentation

As per the scope of the report, fetal and neonatal monitoring devices are machines used for monitoring and designed to care for the unique needs of unborn and newborn babies. The Asia-Pacific Fetal Neonatal Monitoring Market is segmented By Product Type (Fetal Monitoring Devices (Heart Rate Monitors, Uterine Contraction Monitors, Pulse Oximeters, and Other Fetal Monitoring Devices) and Neonatal Monitoring Devices (Cardiac Monitors, Capnographs, Blood Pressure Monitors, Blood Pressure Monitors, Pulse Oximeters and Other Neonatal Monitoring Devices)), End-User (Hospitals, Neonatal Centers And Other End Users) and Geography (China, Japan, India, Australia, South Korea and Rest of Asia-Pacific). The report offers the value (in USD million) for the above segments.

By Product Type
Fetal Monitoring Devices
Heart Rate Monitors
Uterine Contraction Monitor
Pulse Oximeters
Other Fetal Monitoring Devices
Neonatal Monitoring Devices
Cardiac Monitors
Capnographs
Blood Pressure Monitors
Pulse Oximeters
Other Neonatal Monitoring Devices
By End User
Hospitals
Neonatal Care Centers
Other End-users
Geography
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Need A Different Region Or Segment?
Customize Now

Asia-Pacific Fetal & Neonatal Monitoring Market Size Summary

The Asia-Pacific fetal and neonatal monitoring market is poised for significant growth, driven by factors such as high birth rates and the prevalence of preterm births in the region. The market experienced disruptions during the COVID-19 pandemic due to stringent government regulations, which impacted neonatal care and follow-up appointments. However, the resumption of healthcare practices post-pandemic is expected to bolster market expansion. The demand for neonatal devices is on the rise, particularly in countries like India, China, and Indonesia, where preterm birth rates are notably high. This demand is further fueled by the increasing prevalence of congenital heart diseases, necessitating early diagnosis and monitoring through devices like pulse oximeters. Market players are actively engaging in collaborations and awareness campaigns to enhance fetal and neonatal healthcare, contributing to the market's growth trajectory.

Australia is anticipated to hold a significant share of the market, supported by favorable government policies and heightened awareness campaigns. The country's high birth rate and rising instances of preterm births and congenital heart diseases are key factors driving the demand for monitoring devices. The market is characterized by a fragmented landscape with several key players employing strategies such as partnerships and product development to strengthen their presence. Innovations like the AI baby monitor and neonatal ambulances are examples of recent advancements aimed at improving neonatal care. Overall, the combination of high birth rates, the presence of major market players, and increasing awareness is expected to propel the growth of the fetal and neonatal monitoring market in the Asia-Pacific region over the forecast period.

Explore More

Asia-Pacific Fetal & Neonatal Monitoring Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Number of Preterm and Low-weight Births

      2. 1.2.2 Increasing Birth Rate and Advancing Technology in Fetal and Prenatal Monitoring

    3. 1.3 Market Restraints

      1. 1.3.1 Limited Accessibility and Stringent Regulatory Procedures

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product Type

      1. 2.1.1 Fetal Monitoring Devices

        1. 2.1.1.1 Heart Rate Monitors

        2. 2.1.1.2 Uterine Contraction Monitor

        3. 2.1.1.3 Pulse Oximeters

        4. 2.1.1.4 Other Fetal Monitoring Devices

      2. 2.1.2 Neonatal Monitoring Devices

        1. 2.1.2.1 Cardiac Monitors

        2. 2.1.2.2 Capnographs

        3. 2.1.2.3 Blood Pressure Monitors

        4. 2.1.2.4 Pulse Oximeters

        5. 2.1.2.5 Other Neonatal Monitoring Devices

    2. 2.2 By End User

      1. 2.2.1 Hospitals

      2. 2.2.2 Neonatal Care Centers

      3. 2.2.3 Other End-users

    3. 2.3 Geography

      1. 2.3.1 China

      2. 2.3.2 Japan

      3. 2.3.3 India

      4. 2.3.4 Australia

      5. 2.3.5 South Korea

      6. 2.3.6 Rest of Asia-Pacific

Asia-Pacific Fetal & Neonatal Monitoring Market Size FAQs

The Asia-Pacific Fetal & Neonatal Monitoring Market is projected to register a CAGR of 6.20% during the forecast period (2024-2029)

Atom Medical Corp, GE Healthcare, Siemens Healthineers, Becton, Dickinson and Company and Koninklijke Philips NV are the major companies operating in the Asia-Pacific Fetal & Neonatal Monitoring Market.

Asia-Pacific Fetal and Neonatal Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)